Prostate cancer is the second leading cause of death in men. All men, especially African American men, face challenging decisions related to prostate cancer screening. Shared decision making and effective communication should be incorporated by physicians and other health care professionals as proposed by national health organizations. The purpose of this study was to examine the factors associated with patient-physician discussions regarding advantages, disadvantages, and scientific uncertainty for prostate-specific antigen screening. The 2010-2018 National Health Interview Surveys (NHIS) were analyzed. Univariate, bivariate, and multivariate logistic regression models were used to estimate adjusted odds ratios (aORs) and 95% confidence in...
OBJECTIVE: Black men are more prone to harbor prostate cancer. They are more likely to succumb to th...
Cancer is the second leading cause of death in the United States. Prostate cancer is the leading cau...
PURPOSE: Recent clinical practice guidelines on prostate cancer screening using the prostate-specifi...
African American (AA) men face disproportionately higher rates of prostate cancer (PCa) in compariso...
Introduction: Given the ongoing controversies regarding its benefit, prostate specific antigen based...
PURPOSE: Although black men represent a high risk population for prostate specific antigen screening...
PURPOSE: Although black men represent a high risk population for prostate specific antigen screening...
PURPOSE: Although black men represent a high risk population for prostate specific antigen screening...
Sabrina L Dickey,1 Eileen Cormier,1 James Whyte IV,1 Penny A Ralston2 1College of Nursing, 2Center o...
PURPOSE Informed decision making is recommended for prostate cancer screen-ing. I wanted to examine ...
Purpose: Due to controversy regarding pros-tate cancer screening, it is imperative that African Amer...
Thesis (Master's)--University of Washington, 2015-12Background: Most major U.S. medical organization...
Cancer is the second leading cause of death in the United States. Prostate cancer is the leading cau...
Introduction & Objectives: The 2018 United States Preventive Services Task Force recommendations end...
OBJECTIVE: Black men are more prone to harbor prostate cancer. They are more likely to succumb to th...
OBJECTIVE: Black men are more prone to harbor prostate cancer. They are more likely to succumb to th...
Cancer is the second leading cause of death in the United States. Prostate cancer is the leading cau...
PURPOSE: Recent clinical practice guidelines on prostate cancer screening using the prostate-specifi...
African American (AA) men face disproportionately higher rates of prostate cancer (PCa) in compariso...
Introduction: Given the ongoing controversies regarding its benefit, prostate specific antigen based...
PURPOSE: Although black men represent a high risk population for prostate specific antigen screening...
PURPOSE: Although black men represent a high risk population for prostate specific antigen screening...
PURPOSE: Although black men represent a high risk population for prostate specific antigen screening...
Sabrina L Dickey,1 Eileen Cormier,1 James Whyte IV,1 Penny A Ralston2 1College of Nursing, 2Center o...
PURPOSE Informed decision making is recommended for prostate cancer screen-ing. I wanted to examine ...
Purpose: Due to controversy regarding pros-tate cancer screening, it is imperative that African Amer...
Thesis (Master's)--University of Washington, 2015-12Background: Most major U.S. medical organization...
Cancer is the second leading cause of death in the United States. Prostate cancer is the leading cau...
Introduction & Objectives: The 2018 United States Preventive Services Task Force recommendations end...
OBJECTIVE: Black men are more prone to harbor prostate cancer. They are more likely to succumb to th...
OBJECTIVE: Black men are more prone to harbor prostate cancer. They are more likely to succumb to th...
Cancer is the second leading cause of death in the United States. Prostate cancer is the leading cau...
PURPOSE: Recent clinical practice guidelines on prostate cancer screening using the prostate-specifi...